StansenSG
2022-01-20
L
Novavax Covid-19 Vaccine Cleared in Australia<blockquote>Novavax Covid-19 疫苗在澳大利亚获批</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":630390897,"tweetId":"630390897","gmtCreate":1642687953408,"gmtModify":1642687955968,"author":{"id":3578711428062414,"idStr":"3578711428062414","authorId":3578711428062414,"authorIdStr":"3578711428062414","name":"StansenSG","avatar":"https://static.tigerbbs.com/103164c3fe87bb229920af5f907dbf60","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":287,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>L</p></body></html>","htmlText":"<html><head></head><body><p>L</p></body></html>","text":"L","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/630390897","repostId":1105143250,"repostType":4,"repost":{"id":"1105143250","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642686991,"share":"https://www.laohunote.com/m/news/1105143250?lang=zh_CN&edition=full","pubTime":"2022-01-20 21:56","market":"us","language":"en","title":"Novavax Covid-19 Vaccine Cleared in Australia<blockquote>Novavax Covid-19 疫苗在澳大利亚获批</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1105143250","media":"Tiger Newspress","summary":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had gran","content":"<p><html><head></head><body>Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><blockquote><html><head></head><body>由于澳大利亚治疗用品管理局 (TGA) 批准了 Novavax Covid-19 疫苗，Novavax 股价盘前上涨超过 2%。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p>Australia's Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p><blockquote>澳大利亚治疗用品管理局 (TGA) 已批准以下公司开发的 COVID-19 疫苗进行临时注册：<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯</a>该公司周四宣布，对于 18 岁及以上的人。</blockquote></p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p><blockquote>该国将以Nuvaxovid的品牌接收疫苗。</blockquote></p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world's largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p><blockquote>去年，Novavax (NVAX) 宣布与澳大利亚达成预购协议 (APA)，购买 5100 万剂疫苗，其中包括额外交付 1000 万剂疫苗的选择权。全球最大的疫苗制造商印度血清研究所（SII）将向澳大利亚提供首批疫苗。</blockquote></p><p>"The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax's increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia," said Novavax (NVAX) CEO Stanley C. Erck.</p><p><blockquote>Novavax (NVAX) 首席执行官 Stanley C. Erck 表示：“TGA 批准Nuvaxovid临时注册反映了 Novavax 在全球范围内不断增长的势头，也是第一个获准在澳大利亚使用的基于蛋白质的 COVID-19 疫苗。”</blockquote></p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p><p><blockquote>12 月，该公司的 COVID-19 疫苗 NVX-CoV2373 获得了包括欧洲药品管理局（EMA）和世界卫生组织在内的多个监管机构的批准。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax Covid-19 Vaccine Cleared in Australia<blockquote>Novavax Covid-19 疫苗在澳大利亚获批</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax Covid-19 Vaccine Cleared in Australia<blockquote>Novavax Covid-19 疫苗在澳大利亚获批</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2022-01-20 21:56</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.</p><p><blockquote><html><head></head><body>由于澳大利亚治疗用品管理局 (TGA) 批准了 Novavax Covid-19 疫苗，Novavax 股价盘前上涨超过 2%。</body></html></blockquote></p><p><img src=\"https://static.tigerbbs.com/8bd516836472463166488720fec8e99f\" tg-width=\"852\" tg-height=\"650\" referrerpolicy=\"no-referrer\"/></p><p><blockquote></blockquote></p><p>Australia's Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by <a href=\"https://laohu8.com/S/NVAX\">Novavax </a> for those aged 18 years and above, the company announced Thursday.</p><p><blockquote>澳大利亚治疗用品管理局 (TGA) 已批准以下公司开发的 COVID-19 疫苗进行临时注册：<a href=\"https://laohu8.com/S/NVAX\">诺瓦瓦克斯</a>该公司周四宣布，对于 18 岁及以上的人。</blockquote></p><p>The country will receive the vaccine shipments under the brand name Nuvaxovid.</p><p><blockquote>该国将以Nuvaxovid的品牌接收疫苗。</blockquote></p><p>Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world's largest vaccine manufacturer is set to supply the initial doses to Australia.</p><p><blockquote>去年，Novavax (NVAX) 宣布与澳大利亚达成预购协议 (APA)，购买 5100 万剂疫苗，其中包括额外交付 1000 万剂疫苗的选择权。全球最大的疫苗制造商印度血清研究所（SII）将向澳大利亚提供首批疫苗。</blockquote></p><p>"The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax's increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia," said Novavax (NVAX) CEO Stanley C. Erck.</p><p><blockquote>Novavax (NVAX) 首席执行官 Stanley C. Erck 表示：“TGA 批准Nuvaxovid临时注册反映了 Novavax 在全球范围内不断增长的势头，也是第一个获准在澳大利亚使用的基于蛋白质的 COVID-19 疫苗。”</blockquote></p><p>In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.</p><p><blockquote>12 月，该公司的 COVID-19 疫苗 NVX-CoV2373 获得了包括欧洲药品管理局（EMA）和世界卫生组织在内的多个监管机构的批准。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105143250","content_text":"Novavax shares rose over 2% premarket as Australia's Therapeutic Goods Administration (TGA) had granted the approval of Novavax Covid-19 vaccine.Australia's Therapeutic Goods Administration (TGA) has granted the approval for provisional registration of the COVID-19 vaccine developed by Novavax for those aged 18 years and above, the company announced Thursday.The country will receive the vaccine shipments under the brand name Nuvaxovid.Last year, Novavax (NVAX) announced an advance purchase agreement (APA) with Australia for 51M doses of the vaccine including an option to deliver additional 10M doses. Serum Institute of India (SII), the world's largest vaccine manufacturer is set to supply the initial doses to Australia.\"The grant of provisional registration of Nuvaxovid by the TGA reflects Novavax's increasing momentum around the globe and represents the first-protein based COVID-19 vaccine authorized for use in Australia,\" said Novavax (NVAX) CEO Stanley C. Erck.In December, the company’s COVID-19 vaccine identified as NVX-CoV2373 was cleared by multiple regulatory agencies, including the European Medicines Agency (EMA) and the World Health Organization.","news_type":1,"symbols_score_info":{"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":3690,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":1,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/630390897"}
精彩评论